Open AccessWeight-based dosing of lenvatinib for advanced hepatocellular carcinoma
Author(s) -
Satoshi Ogasawara,
Yoshihiko Ooka,
Naoya Kato
Publication year - 2020
Publication title -
hepatobiliary surgery and nutrition
Language(s) - English
Resource type - Journals
eISSN - 2304-389X
pISSN - 2304-3881
DOI - 10.21037/hbsn.2019.09.21
Subject(s) - lenvatinib , sorafenib , medicine , hepatocellular carcinoma , oncology , dosing , tyrosine kinase inhibitor , fibroblast growth factor receptor , pharmacology , receptor , fibroblast growth factor , cancer